======= SPC25 ======= == Gene Information == * **Official Symbol**: SPC25 * **Official Name**: SPC25 component of NDC80 kinetochore complex * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57405|57405]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9HBM1|Q9HBM1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SPC25&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SPC25|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609395|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as a component of the essential kinetochore- associated NDC80 complex, which is required for chromosome segregation and spindle checkpoint activity (PubMed:14699129, PubMed:14738735). Required for kinetochore integrity and the organization of stable microtubule binding sites in the outer plate of the kinetochore (PubMed:14738735, PubMed:14699129). The NDC80 complex synergistically enhances the affinity of the SKA1 complex for microtubules and may allow the NDC80 complex to track depolymerizing microtubules (PubMed:23085020). {ECO:0000269|PubMed:14699129, ECO:0000269|PubMed:14738735, ECO:0000269|PubMed:23085020}. |Spc7| |Spindle Spc25| |Ndc80 complex| |mitotic spindle organization| |condensed chromosome kinetochore| |microtubule cytoskeleton organization involved in mitosis| |spindle organization| |chromosome segregation| |microtubule cytoskeleton organization| |cell division| |mitotic cell cycle process| |microtubule-based process| |mitotic cell cycle| |cell cycle process| |cytoskeleton organization| |cell cycle| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-1.77| |[[:results:exp447|Amiloride 100μM R08 exp447]]|-1.74| |[[:results:exp261|ABT-702 5μM R06 exp261]]|1.74| |[[:results:exp336|Asunaprenir 3μM R07 exp336]]|1.88| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|2.15| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|2.42| |[[:results:exp421|VHL-ligand-1 20μM R07 exp421]]|2.46| |[[:results:exp293|Myriocin 25μM R06 exp293]]|2.49| |[[:results:exp406|Thalidomide 20μM R07 exp406]]|2.51| ^Gene^Correlation^ |[[:human genes:c:casc5|CASC5]]|0.416| Global Fraction of Cell Lines Where Essential: 682/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|27/28| |blood|27/28| |bone|25/26| |breast|30/33| |central nervous system|50/56| |cervix|4/4| |colorectal|16/17| |esophagus|10/13| |fibroblast|1/1| |gastric|13/16| |kidney|17/21| |liver|19/20| |lung|70/75| |lymphocyte|15/16| |ovary|22/26| |pancreas|24/24| |peripheral nervous system|14/16| |plasma cell|13/15| |prostate|1/1| |skin|23/24| |soft tissue|8/9| |thyroid|2/2| |upper aerodigestive|21/22| |urinary tract|27/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1078 * **Expression level (log2 read counts)**: 4.87 {{:chemogenomics:nalm6 dist.png?nolink |}}